Antigen preparation for immunological studies in systemic autoimmune diseases

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 193-202

  Zampieri, Sandra ^a   Ghirardello, Anna ^a   Rossini, Katia ^a   Iaccarino, Luca ^a   Bassi, Nicola ^a   Atzeni, Fabiola ^b   Sarzi Puttini, Piercarlo ^b   Doria, Andrea ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Antigenic source; Autoantigens; Cell extracts; Immunoassays; Lymphocytes; TRIzol

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; ANTIGEN;

AUTOIMMUNE DISEASE; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; CONFERENCE PAPER; COUNTER IMMUNOELECTROPHORESIS; EXTRACTION; IMMUNOBLOTTING; IMMUNOLOGICAL TECHNIQUE; LYMPHOCYTE; LYSIS; TISSUE SPECIFICITY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; REVIEW;

ANTIGENS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; LYMPHOCYTES;

EID: 34848920931     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.023     Document Type: Conference Paper

References (46)

1. REICHLIN, M. 1998. Systemic lupus erythematosus and pregnancy. J. Reprod. Med. 43: 355-360.
2. HERRMANN, M., T. WINKLER, U. GAILP, et al. 2000. Etiopathogenesis of systemic lupus erythematosus. Int. Arch. Allergy Immunol. 123: 28-35.
3. BUYON, J.P. & R.M. CLANCY. 2003. Neonatal lupus: review of proposed pathogenesis and clinical data from US-based Research Registry for Neonatal Lupus. Autoimmunity 36: 41-50.
4. COSTEDOAT-CHALUMEAU, N., S. GEORGIN-LAVIALLE, Z. AMOURA, et al. 2005. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus 14: 660-664.
5. WALDMAN, M. & M.P. MADAIO. 2005. Pathogenic autoantibodies in lupus nephritis. Lupus 14: 19-24.
6. ARBUCKLE, M.R., M.T. MCCLAIN, M.V. RUBERTONE, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 1526-1533.
7. POOLE, B.D., R.H. SCOFIELD, J.B. HARLEY, et al. 2005. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63-70.
8. HARLEY, J.B. & J.A. JAMES. 2006. Epstein-bar virus infection induces lupus autoimmunity. Bull Hosp. Joint Dis. 64: 45-50.
9. CASIANO, C.A., R.L. OCHS & E.M. TAN. 1998. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 5: 183-190.
10. ROSEN, A. & L. CASCIOLA-ROSEN. 1999. Autoantigens as substrates for apoptotic proteases. Implications for the pathogenesis of systemic autoimmune diseases. Cell Death Differ. 6: 6-12.
11. ZAMPIERI, S., W. DEGEN, A. GHIRARDELLO, et al. 2001. Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 60: 72-76.
12. GAIPL, U.S., A. SHERIFF, S. FRANZ, et al. 2006. Inefficient clearance of dying cells and autoreactivity. Curr. Top. Microbiol. Immunol. 305: 161-176.
13. PATEL, V.A., A. LONGACRE, K. HSIAO, et al. 2006. Apoptotic cells, at all stags of the death process, trigger characteristic signalling events that are divergent from and dominant over those triggered by necrotic cells. Implications for the delayed clearance model of autoimmunity. J. Biol. Chem. 281: 4663-4670.
14. MAUERMANN, N., Z. STHOEGER, H. ZINGER, et al. 2004. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients. Clin. Exp. Immunol. 137: 513-520.
15. ALARCON-SEGOVIA, D., J.A. TUMLIN, R.A. FURIE, et al. 2003. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo controlled study. Arthritis Rheum. 48: 442-454.
16. HIEPE, F., T. DORNER & G.R. BURMESTER. 2000. Editorial overview: antinuclear antibody and extractable nuclear antigen-related disease. Int. Arch. Allergy Immunol. 123: 5-9.
17. MCCARTY, G., D.W. VALENCIA & M.J. FRITZLER. 1984. Antinuclear Antibodies: Contemporary Techniques and Clinical Application to Connective Tissue Diseases. 1-96. Oxford University Press. NY
18. MURO, Y. 2005. Antinuclear antibodies. Autoimmunity 38: 3-9.
19. VAN VENROOIJ, W.J., P. CHARLES & R.N. MAINI. 1991. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. JIM 140: 181-189.
20. TAN, E.M., T.E.W. FELTKAMP, J.S. SMOLEN, et al. 1997. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40: 1601-1611.
21. BERNSTEIN, R.M., C.C. BUNN & G.R.V. HUGHES. 1982. Identification of antibodies to acidic proteins by counterimmunoelectrophoresis. Ann. Rheum. Dis. 41: 554-555.
22. ELKON, K.B. & P.W. JANKOWSKY. 1985. Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP and Jo-1 proteins defined by two dimensional gel electrophoresis and immunoblotting. J. Immunol. 134: 3819-3824.
23. GHIRARDELLO, A., S. ZAMPIERI, L. IACCARINO, et al. 2005. Anti-Mi-2 antibodies. Autoimmunity 38: 79-83.
24. GHIRARDELLO, A., A. DORIA, P. VESCO, et al. 1996. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol. Int. 16: 145-150.
25. ZAMPIERI, S., A. GHIRARDELLO, A. DORIA, et al. 2000. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases. JIM 239: 1-11.
26. BASU, D. & J.D. REVEILLE. 2005. Anti-Scl-70. Autoimmunity 38: 65-72.
27. MIGLIORINI, P., C. BALDINI, V. ROCCHI, et al. 2005. Anti-Sm and anti-RNP antibodies. Autoimmunity 38: 47-54.
28. LERNER, M.R. & J.A. STEITZ. 1979. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 76: 5495-5499.
29. PRUIJN, G. J. M., R.L. SLOBBE & W.J. VAN VENROOIJ. 1991. Structure and function of Ro and La RNPs. Mol. Biol. Rep. 14: 43-48.
30. GHIRARDELLO, A., S. ZAMPIERI, E. TARRICONE, et al. 2006. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39: 217-221.
31. ZAMPIERI, S., A. GHIRARDELLO, L. IACCARINO, et al. 2005. Anti-Jo-1 antibodies. Autoimmunity 38: 73-78.
32. HIRAKATA, M., A. SUWA, S. NAGAI, et al. 1999. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J. Immunol. 162: 2315-2320.
33. MADDISON, P.J., R.P. SKINNER, P. VLACHOJIANNOPOULOS, et al. 1985. Antibodies to nRNP, Sm, Ro (SSA), and La (SSB) detected by ELISA: their specificity and interrelations in connective tissue disease sera. Clin. Exp. Immunol. 62: 337-345.
34. SCHMITT, J. & W. PAPISH. 2002. Recombinant autoantigens. Autoimmunity Rev. 1: 79-88.
35. GONZALES-BUITRAGO, J.M. & C. GONZALES. 2006. Present and future in autoimmunity laboratory. Clin. Chim. Acta 365: 50-57.
36. BINDER, S.R. 2006. Autoantibody detection using multiplex technologies. Lupus 15: 412-421.
37. ROUQUETTE, A.M. & C. DESGRUELLES. 2006. Detection of antibodies to dsDNA: an overview of laboratory assays. Lupus 15: 403-407.
38. SHOVMAN, O., B. GILBURD, G. ZANDMAN-GODDARD, et al. 2005. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 38: 105-109.
39. BEN-CHETRIT, E., R.I. FOX & E.M. TAN. 1990. Dissociation of immune response to SS-A (Ro) 52 kDa and 60 kDa polypeptides in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheum. 33: 349-355.
40. GHIRARDELLO, A., A. DORIA, S. ZAMPIERI, et al. 2000. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann. Rheum. Dis. 59: 975-981.
41. ENCHEVA, V., S.B. GHARBIA, R. WAIT, et al. 2006. Comparison of extraction procedures for proteome analyses of Streptococcus penumoniae and basic reference map. Proteomics 6: 3306-3317.
42. SMEIKAL, G.B., M.H. ROBINSON, N.P. LAWRENCE, et al. 2006. Increased protein yields from Esherichia coli using pressure-cycling technology. J. Biol. Techniques 17: 173-175.
43. LOONEY, R.J., J. ANOLIK & I. SANZ. 2006. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells. Lupus 13: 381-390.
44. GLADKEVICH, A., S.A. NELEMANS, H.F. KAUFFMAN, et al. 2005. Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm. 6: 317-330.
45. MUDD, P.A., B.N. TEAGUE & A.D. FARRIS. 2006. Regulatory T cells and systemic lupus erythematosus. Scand. J. Immunol. 64: 211-218.
46. BANERJEE, S., A. SMALLWOOD, A.E. CHAMBERS, et al. 2003. Quantitative recovery of immunoreactive proteins from clinical samples following DNA and RNA isolation. Biotechniques 5: 450-456.